| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 3,109 | -254 |
| Net decrease in cash, cash equivalents and restricted cash | -4,594 | -4,404 |
| Cash and cash equivalents at beginning of period | 9,847 | - |
| Cash and cash equivalents at end of period | 5,253 | - |
PALISADE BIO, INC. (PALI)
PALISADE BIO, INC. (PALI)